HOLOGIC INC (HOLX) Stock News
NASDAQ:HOLX - Nasdaq - US4364401012 - Common Stock
HOLX Latest News and Analysis
New Report Reveals Alarming Decline in Women’s Cancer Testing Worldwide
FDA Warns Hologic Over BioZorb Manufacturing Violations
FDA issues warning to Hologic, citing manufacturing and safety violations for BioZorb devices. Patient safety risks and reporting failures highlighted
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2025
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Hologic to Announce Financial Results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025
Hologic Completes Acquisition of Gynesonics, Inc.
Hologic (HOLX) Falls More Steeply Than Broader Market: What Investors Need to Know
Hologic (HOLX) concluded the recent trading session at $71.74, signifying a -0.49% move from its prior day's close.
Hologic (HOLX) Flat As Market Sinks: What You Should Know
Hologic (HOLX) closed at $72.68 in the latest trading session, marking no change from the prior day.
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Hologic Teams Up With the CDC to Combat H5N1 Bird Flu: Stock to Gain?
Via an agreement with the CDC, Hologic is set to develop ASRs for launching the H5N1 bird flu test.
First Week of December 2025 Options Trading For Hologic (HOLX)
Here's Why Hologic (HOLX) Fell More Than Broader Market
Hologic (HOLX) closed the most recent trading day at $70.76, moving -0.99% from the previous trading session.
Hologic to Contribute to H5N1 Bird Flu Test Development via Agreement Issued by CDC
Oversold Conditions For Hologic (HOLX)
Hologic (HOLX) Stock Moves -1.93%: What You Should Know
In the closing of the recent trading day, Hologic (HOLX) stood at $73.64, denoting a -1.93% change from the preceding trading day.
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic Trades at 17.62X P/E: Should You Buy, Sell or Hold the Stock?
Despite the current challenges, HOLX's portfolio strength and international growth prospects make it worth holding on to.
Hologic Statement on USPSTF Draft Cervical Cancer Screening Guidelines
Martin Madaus Elected to Hologic Board of Directors
Hologic (HOLX) Down 1.7% Since Last Earnings Report: Can It Rebound?
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HOLX Stock Set to Gain From New Study Data on Genius AI Detection 2.0
Hologic upholds its focus on equity with new research findings on its Breast Imaging AI solution.
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Hologic to Debut AI-Powered Innovations at RSNA 2024: Stock to Gain?
HOLX will unveil breakthrough innovations at this year's RSNA, focusing on imaging solutions and AI.